Hypercalcemia and Malignancy

Albright F. Case records of the Massachusetts General Hospital. New Engl. J. Med. 255 (1941) 789.

Bender R. A. Hansen H. Hypercalcaemia in bronchogenic carcinoma. Ann. intern. Med. 80 (1974) 205.

Benson R. C. Biggs B. L. Arnaud C. D. Immuno-reactive forms of parathyroid hormone in primary and ectopic hyperparathyroidism (abstract). Clin. Res. 21 (1973) 819.

Benson R. C. Biggs B. L. Pickard B. M. Arnaud C. D. Radioimmunoassay of parathyroid hormone in hypercalcaemic patients with malignant disease. Amer. J. Med. 56 (1974) 821.

Brereton H. D. Halushka P. V. Alexander R. W. Mason D. M. Kaiser H. R. Devita V. T. Jr. Indomethacin-responsive hypercalcaemia in a patient with renal-cell adenocarcinoma. New Engl. J. Med. 291 (1974) 83.

Farr H. W. Fahey T. J. Jr. Nash A. G. Farr C. M. Primary hyperparathyroidism and cancer. Amer. J. Surg. 126 (1973) 539.

Franklin R. B. Tashjian A. H. Jr. Intravenous infusion of prostaglandin E₂ raises plasma calcium concentration in the rat. Endocrinology 97 (1975) 240.

Fraser P. Healy M. Rose N. Watson L. Discriminant functions in differential diagnosis of hypercalcaemia. Lancet 1 (1971) 1314.

Galasko C. S. B. Burn J. I. Hypercalcaemia in patients with advanced mammary cancer. Brit. med. J. 3 (1971) 573.

Gordan G. S. Cantino T. J. Erhardt L. Hansen J. Lubich W. Osteolytic sterol in human breast cancer. Science 151 (1966) 1226.

Haddad J. G. Jr. Couranz S. J. Avioli L. V. Circulating phytosterols in normal females, lactating mothers and breast cancer patients. J. clin. Endocr. 30 (1970) 174.

Heath D. A. Shimkin P. M. Wolfe D. R. The preoperative diagnosis of primary hyperparathyroidism by selective venous catheterisation of neck veins in patients with known malignant disease. J. clin. Endocr. 38 (1974) 618.

Heath D. A. Aurbach C. D. Ectopic production of parathyroid hormone: A prototype of non-endocrine hormone synthesis, in Endocrinology and Diabetes, eds. Krystan Shaw New York, Grune and Stratton (1975).

Horton J. E. Raisz L. G. Simmons H. A. Oppenhein J. J. Mergenhagen S. E. Bone resorbing activity in supernatant fluid from cultured human peripheral blood leucocytes. Science 177 (1972) 793.

Kaplan L. Katz A. D. Ben-Isaac C. Massry S. G. Malignant neoplasms and parathyroid adenoma. Cancer 28 (1971) 401.

Klein D. C. Raisz L. G. Prostaglandins: Stimulation of bone resorption in tissue culture. Endocrinology 86 (1970) 1436.

Luben R. A. Mundy G. R. Trummel C. L. Raisz L. G. Partial purification of osteoclast-activating factor from phytohaemoglutinin-stimulated human leucocytes. J. clin. Invest. 53 (1974) 1473.

Mundy G. R. Raisz L. G. Cooper R. A. Schechter G. P. Salmon S. E. Evidence for the secretion of an osteoclast stimulating factor in myeloma. New Engl. J. Med. 291 (1974) 1041.

Myers W. P. L. Hypercalcaemia in neoplastic disease. Arch. Surg. 80 (1960) 308.

Nordin B. E. C. Peacock M. The role of the kidney in serum calcium homeostasis. Calcitonin 1969 Proceedings of the Second International Symposium, ed. Taylor S. London, Heinemann (1970).

Ommen G. S. Roth S. I. Baker W. H. Hyperparathyroidism associated with malignant tumours of non-parathyroid origin. Cancer 24 (1969) 1004.

Powell D. Singer F. R. Murray T. M. Minkin C. Potts J. T. Jr. Non-parathyroid humoral hypercalcaemia in patients with neoplastic diseases. New Engl. J. Med. 289 (1973) 176.

Riggs B. L. Arnaud C. D. Reynolds J. C. Smith L. H. Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to non-parathyroid cancer. J. clin. Invest. 50 (1971) 2079.

Robertson R. P. Baylink D. J. Marini J. J. Adkison H. W. Elevated prostaglandins and suppressed parathyroid hormone associated with hypercalcaemia and renal cell carcinoma. J. clin. Endocr. 41 (1975) 164.

Roof B. S. Carpenter B. Fink D. J. Gordan G. S. Some thoughts on the nature of ectopic parathyroid hormones. Amer. J. Med. 50 (1971) 686.

Saint-Hillier Y. Dupond J. L. Colomb H. Perol C. Le traitement des hypercalcemies. Interet de la mithramycine. Press. méd. 4 (1975) 1290.

Schussler G. C. Verso M. A. Nemoto T. Phosphaturia in hypercalcaemic breast cancer patients. J. clin. Endocr. 35 (1972) 497.

Seyberth H. W. Segre G. V. Morgan J. L. Sweetman B. J. Potts J. T. Jr. Oates J. A. Prostaglandins as mediators of hypercalcaemia associated with certain types of cancer. New Engl. J. Med. 293 (1975) 1278.

Tashjian A. H. Jr. Levine L. Munson P. L. Immunochemical identification of parathyroid hormone in non-parathyroid neoplasms associated with hypercalcaemia. J. exp. Med. 119 (1964) 467.

Tashjian A. H. Jr. Voelkel E. F. Levine L. Goldhaber P. Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E₂ . J. exp. Med. 136 (1972) 1329.

Tashjian A. H. Jr. Voelkel E. F. Goldhaber P. Levine L. Successful treatment of hypercalcaemia by indomethacin in mice bearing a prostaglandin-producing fibrosarcoma. Prostaglandins 3 (1973) 515.

Tashjian A. H. Jr. Voelkel E. F. McDonough J. Levine L. Hydrocortisone inhibits prostaglandin production by mouse fibrosarcoma cells. Nature (Lond.) 258 (1975) 739.

Thalassinos N. C. Joplin G. F. Failure of corticosteroid therapy to correct the hypercalcaemia of malignant disease. Lancet 2 (1970) 537.

Thomas A. N. Loken H. F. Gordan G. S. Goldman L. Hypercalcaemia of metastatic breast cancer. Surgical Forum 11 (1960) 70.

Warwick O. H. Yendt E. R. Olin J. S. The clinical features of hypercalcaemia associated with malignant disease. Canad. Med. Assoc. J. 85 (1961) 719.

Wills M. R. Value of plasma chloride concentration and acid-base status in the differential diagnosis of hyperparathyroidism from other causes of hypercalcaemia. J. clin. Path. 24 (1971) 219.

Zilva J. F. Nicholson J. P. Plasma phosphate and potassium levels in the hypercalcaemia of malignant disease. J. clin. Endocr. 36 (1973) 1019.